Home › Funds › ADVENT CAPITAL MANAGEMENT /DE/ › RGEN

ADVENT CAPITAL MANAGEMENT /DE/ position in RGEN

REPLIGEN CORP · Health Care

ADVENT CAPITAL MANAGEMENT /DE/ reported holding 23,815,000 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$24.5M, representing 0.72% of its reported portfolio and ranking #42 among its reported holdings. ADVENT CAPITAL MANAGEMENT /DE/ has disclosed RGEN holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)23.82M sh
Reported value held$24.49M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADVENT CAPITAL MANAGEMENT /DE/'s RGEN position evolved

ADVENT CAPITAL MANAGEMENT /DE/ first disclosed a stake in RGEN in Q3 2023 at 2,780,000 shares (US$4.0M). The position peaked in Q2 2025 at 31,004,000 shares, worth US$30.9M. Across 7 filings, ADVENT CAPITAL MANAGEMENT /DE/ increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 23,815,000 shares valued at US$24.5M — an increase of 3,032,000 shares quarter over quarter.. Notable position changes include a 104% increase in Q4 2023 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.78M $3.98M New
Q4 2023 5.67M $6.36M Add
Q2 2025 31.00M $30.86M New
Q3 2025 28.13M $28.36M Reduce
Q4 2025 24.43M $26.82M Reduce
Q1 2026 20.78M $20.37M Reduce
Q2 2026 23.82M $24.49M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has ADVENT CAPITAL MANAGEMENT /DE/ held RGEN?

ADVENT CAPITAL MANAGEMENT /DE/ has disclosed RGEN holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

What is ADVENT CAPITAL MANAGEMENT /DE/'s current position in RGEN?

As of Q2 2026, ADVENT CAPITAL MANAGEMENT /DE/ holds 23.82M shares of RGEN (REPLIGEN CORP), valued at $24.49M, representing 0.72% of its reported portfolio and ranking #42.

Has ADVENT CAPITAL MANAGEMENT /DE/ been buying or selling RGEN?

In the latest 13F filing (Q2 2026), ADVENT CAPITAL MANAGEMENT /DE/ increased its position in RGEN. The position peaked in Q2 2025 at 31.00M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.